Introducing More Potent PARP Inhibitors more
New Agents for Burkitt's Lymphoma May Reduce Immunosuppression more
Newly Identified Mechanism Links Obesity with Breast Cancer more
Novel Antibody Targets Glypican-3 in Liver Cancer more
Genomic Marker Better Informs Treatment Choices for CRPC more
Virtual Entity Yields
Genomic technologies have revolutionized
cancer research, but not without analytical challenges.
No single researcher can manage the vast datasets
generated by next-generation sequencing and other
modern genomic tools.
Continue this story
A service of the National Cancer Institute